Whitney Ijem

Stock Analyst at Canaccord Genuity

(1.03)
# 2106
Out of 5,370 analysts
111
Total ratings
44.26%
Success rate
-2.53%
Average return
21 Stocks
Name Action PT Current % Upside Ratings Updated
TSHA Taysha Gene Therapie...
Maintains: Strong Buy
9 11
2.54 333.07% 10 Jun 3, 2025
RCKT Rocket Pharmaceutica...
Maintains: Buy
34 11
2.88 281.94% 8 Jun 3, 2025
NTLA Intellia Therapeutic...
Maintains: Buy
74 54
8.96 502.68% 6 Jun 3, 2025
PVLA Palvella Therapeutic...
Maintains: Buy
53 52
23.51 121.18% 3 May 16, 2025
ARCT Arcturus Therapeutic...
Maintains: Buy
68 66
12.89 412.02% 6 May 13, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
28 11
8.25 33.33% 6 Apr 30, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
32 39
6.28 521.02% 5 Apr 15, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
81 92
62.34 47.58% 7 Apr 8, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
385 390
308.78 26.3% 8 Mar 21, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
9 9
n/a n/a 2 Mar 17, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
18 6
0.62 867.74% 6 Mar 13, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
121 136
37.03 267.27% 8 Feb 18, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Hold
408 424
450.66 -5.92% 8 Feb 12, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
13 13
n/a n/a 6 Nov 14, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
148 150
20.99 614.63% 3 Nov 7, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
93 84
56.19 49.49% 8 Oct 30, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
6 30
n/a n/a 2 Jul 5, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
260
n/a n/a 1 Feb 7, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Jan 21, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Overweight
120 240
4.51 5221.51% 4 Jul 23, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Overweight
33 0
n/a n/a 2 Feb 26, 2018